Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
In this study the investigators test the hypothesis that alteplase given intra coronary after
PCI reduce infarct size in patients with ST-elevation myocardial infarction(STEMI) and
impaired microvascular function defined as a value of index of microvascular resistance (IMR)
>30.